Guyana signs up for trailblazing deal to produce drugs

Paul Kagame (second from left) is joined by Mia Mottley, Barbadian prime minister (third from left); Ursula von der Leyen, President of the EU Commission (fourth from left); Werner Hoyer, President of the European Investment Bank Group (right); and Holm Keller, Chairman of kENUP Foundation, for the launch of Pharmaceutical Equity for Global Public Health Initiative. / Village Urugwiro

Guyana has signed on to an agreement that would see pharmaceutical companies here eventually manufacturing drugs for distribution to Caribbean, Latin American and African countries.

The South-South initiative was yesterday announced in Sharm El-Sheikh, Egypt, on the sidelines of the COP 27 summit and has the support of the European Union and the World Health Organization.

“The Pharmaceutical Equity for Global Public Health Equity, which is being launched today, is a manifestation of actionable South-South cooperation. It is a model through which the countries of the South can assume greater responsibility for responding to health and other challenges. The Co-operative Republic of Guyana is pleased to be associated with the convening of this initiative. We pledge our support to this undertaking and to improving global public health equity,” President Irfaan Ali declared in a virtual presentation yesterday from Guyana, where he had joined Prime Minister of Barbados Mia Mottley and President of Rwanda Paul Kagame on the sidelines of the COP 27 Summit.